Your browser doesn't support javascript.
loading
Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study).
Solis-Hernandez, Mª Pilar; Fernandez Del Valle, Ana; Carmona-Bayonas, Alberto; Garcia-Carbonero, Rocio; Custodio, Ana; Benavent, Marta; Alonso Gordoa, Teresa; Nuñez-Valdovino, Bárbara; Sanchez Canovas, Manuel; Matos, Ignacio; Alonso, Vicente; Lopez, Carlos; Viudez, Antonio; Izquierdo, Marta; Calvo-Temprano, David; Grande, Enrique; Capdevila, Jaume; Jimenez-Fonseca, Paula.
Afiliação
  • Solis-Hernandez MP; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Fernandez Del Valle A; Radiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Carmona-Bayonas A; Hematology & Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain.
  • Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario 12 de Octubre, imas12, CNIO, UCM, CIBERONC, Madrid, Spain.
  • Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain.
  • Benavent M; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Alonso Gordoa T; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Nuñez-Valdovino B; Medical Oncology Department, Hospital Clínico de la Universidad de Chile, Santiago de Chile, Chile.
  • Sanchez Canovas M; Hematology & Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain.
  • Matos I; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Alonso V; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Lopez C; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Viudez A; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Izquierdo M; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Calvo-Temprano D; Radiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Grande E; Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain.
  • Capdevila J; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. palucaji@hotmail.com.
Br J Cancer ; 121(7): 537-544, 2019 10.
Article em En | MEDLINE | ID: mdl-31477779
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Tumores Neuroendócrinos / Sunitinibe / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Tumores Neuroendócrinos / Sunitinibe / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha